Pain Coping Skills Training for Patients Receiving Hemodialysis
JAMA Internal Medicine · 2025
DOI: 10.1001/jamainternmed.2024.7140 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift JAMA Internal Medicine, 2025. Verfasst von Laura M Dember und 34 weiteren Autor:innen. Beteiligte Einrichtung: Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia. Hauptthemen laut MEDLINE: Adaptation, Psychological, Chronic Pain, Cognitive Behavioral Therapy, Kidney Failure, Chronic. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDA NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Importance Chronic pain is common among individuals with dialysis-dependent kidney failure.
Objective
To evaluate the effectiveness of pain coping skills training (PCST), a cognitive behavioral intervention, on pain interference. Design, Setting, and Participants This multicenter randomized clinical trial of PCST vs usual care was conducted across 16 academic centers and 103 outpatient dialysis facilities in the US. Adults undergoing maintenance hemodialysis and experiencing chronic pain were randomly assigned to PCST or usual care in a 1:1 ratio. Participants were followed in the trial for 36 weeks. Enrollment began on January 4, 2021, and follow-up ended on December 21, 2023.
Interventions
PCST consisting of 12 weekly coach-led sessions via video or telephone conferencing, followed by 12 weeks of daily interactive voice response sessions. Usual care had no trial-driven pain intervention. Main Outcomes The primary outcome was pain interference measured with the Brief Pain Inventory (BPI) Interference subscale (score range of 0-10, with higher scores indicating more pain interference). Secondary outcomes included pain intensity, pain catastrophizing, quality of life, depression, and anxiety.
Results
A total of 643 participants (mean [SD] age, 60.3 [12.6] years; 288 [44.8%] female) were randomized, with 319 assigned to PCST and 324 assigned to usual care. At week 12 (primary end point), the PCST group had a larger reduction in the BPI Interference score than the usual care group (between-group difference, −0.49; 95% CI, −0.85 to −0.12; P = .009). The effect persisted at week 24 (between-group difference in BPI Interference score, −0.48; 95% CI, −0.86 to −0.11) but was diminished at week 36 (between-group difference in BPI Interference score, −0.34; 95% CI, −0.72 to 0.04). A decrease in BPI Interference score greater than 1 point (minimal clinically important difference) occurred in 143 of 281 participants (50.9%) in the PCST group vs 108 of 295 participants (36.6%) in the usual care group at 12 weeks (odds ratio, 1.79; 95% CI, 1.28-2.49) and 142 of 258 participants (55.0%) in the PCST group vs 113 of 264 participants (42.8%) in the usual care group at 24 weeks (odds ratio, 1.59; 95% CI, 1.13-2.24). Favorable changes with PCST were also apparent for secondary outcomes of pain intensity, quality of life, depression, and anxiety at weeks 12 and/or 24, as well as for pain catastrophizing at weeks 24 and 36. Conclusions and Relevance In this randomized clinical trial of patients undergoing maintenance hemodialysis, PCST had benefits on pain interference and other pain-associated outcomes. While the effect on the overall cohort was of modest magnitude, the intervention resulted in a clinically meaningful improvement in pain interference for a substantial proportion of participants. Trial Registration ClinicalTrials.gov Identifier: NCT04571619
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Department of Biostatistics, Epidemiology and Informatics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle.
- Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
- Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston.
- Division of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.
Förderung
- NIDDK NIH HHS
- NIDA NIH HHS
- NCATS NIH HHS
Zitieren
APA
Dember, L. M., Hsu, J. Y., Mehrotra, R., Cavanaugh, K. L., Kalim, S., Charytan, D. M., Fischer, M. J., Jhamb, M., Johansen, K. L., Becker, W. C., Pellegrino, B., Eneanya, N. D., Schrauben, S. J., Pun, P. H., Unruh, M. L., Morasco, B. J., Mehta, M., Miyawaki, N., Penfield, J., …, & HOPE Consortium (2025). Pain Coping Skills Training for Patients Receiving Hemodialysis. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2024.7140
Vancouver
Dember LM, Hsu JY, Mehrotra R, Cavanaugh KL, Kalim S, Charytan DM, et al. Pain Coping Skills Training for Patients Receiving Hemodialysis. JAMA Internal Medicine. 2025. doi:10.1001/jamainternmed.2024.7140
BibTeX
@article{Dember2025,
author = {Dember, Laura M and Hsu, Jesse Y and Mehrotra, Rajnish and Cavanaugh, Kerri L and Kalim, Sahir and Charytan, David M and Fischer, Michael J and Jhamb, Manisha and Johansen, Kirsten L and Becker, William C and Pellegrino, Bethany and Eneanya, Nwamaka D and Schrauben, Sarah J and Pun, Patrick H and Unruh, Mark L and Morasco, Benjamin J and Mehta, Mansi and Miyawaki, Nobuyuki and Penfield, Jeffrey and Bernardo, Leah and Brintz, Carrie E and Cheatle, Martin D and Doorenbos, Ardith Z and Heapy, Alicia A and Keefe, Francis J and Krebs, Erin E and Kuzla, Natalie and Nigwekar, Sagar U and Schmidt, Rebecca J and Steel, Jennifer L and Wetmore, James B and White, David M and Kimmel, Paul L and Cukor, Daniel and HOPE Consortium, HOPE Consortium},
title = {Pain Coping Skills Training for Patients Receiving Hemodialysis},
journal = {JAMA Internal Medicine},
year = {2025},
doi = {10.1001/jamainternmed.2024.7140}
}
EUVIMED